Ebola Diagnosis on the Fast Track

Ebola Diagnosis on the Fast Track

In addition to expedited device approvals for diseases without effective existing treatments, the FDA has also fast-tracked Ebola tests under its emergency responsibilities in the Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA). The FDA’s announcement of emergency use authorizations (EUAs) for Ebola test kits beginning in August 2014 promoted the development of several tests by both public organizations and private industry. Test development has been along the lines of rapid d...

  • by bcarlson@marketresearch.com
  • October 23 2014


Consortium Amplifies miRNA Development

Consortium Amplifies miRNA Development

In our miRNA market research report , we detail some of the developments and research efforts in this promising area of medicine. A data management organization, the RNAcentral Consortium, now offers the website RNAcentral ( http://rnacentral.org ) to serve as a unified resource for all types of noncoding RNA data. It was developed by pooling information from a variety of sources, including databases and tools for browsing, contains approximately 8 million sequences. By combining databases from ...

  • by bcarlson@marketresearch.com
  • October 21 2014


Urgent Care Market Grows Up

Urgent Care Market Grows Up

The estimated 9,400 Urgent care centers (UCCs) in the United States sold over 15 billion dollars worth of services in 2013. These medical clinics in a free-standing location or strip-mall provide an increasingly critical option between a physician’s office and a hospital emergency room. The estimate was made in Kalorama’s U.S. Market for Urgent Care Centers ( http://www.kaloramainformation.com/Urgent-Care-Centers-8430284/ ).

Urgent Care Centers provide walk-in, extended hour access for acute i...

  • by bcarlson@marketresearch.com
  • October 14 2014


Ebola Threat Leads To Fast Track Vaccine Efforts

Ebola Threat Leads To Fast Track Vaccine Efforts

Companies who had vaccine programs for Ebola are speeding them up in the wake of the focus on this disease. Many concerns are aligning with the WHO’s Ebola Response Roadmap, including its call to fast-track access to treatment and vaccine options to address the urgent situation. Kalorama covers the vaccine market including future forecasts in its recent report on the industry.

The Ebola outbreak in Western Africa is mobilizing international health organizations, both public and private, across...


Medical Device Start-Up Flight to Europe and its Market Implications

Medical Device Start-Up Flight to Europe and its Market Implications

Future upsides to the global medical device market may increasingly originate in Europe as many start-ups seek initial market approval within the European Union (EU). Recent criticism of the U.S. FDA has been preoccupied with the relative complexity of clinical trial plans in the United States. At a recent conference, Mark Deem, managing partner of medical device incubator The Foundry LLC, noted the FDA’s deficiencies relating to his issue:

Clinical trials are a particularly sore point - the F...

  • by bcarlson@marketresearch.com
  • October 8 2014
  • vaccine


UK Tackles Flu With Children Before It Reaches Adults

UK Tackles Flu With Children Before It Reaches Adults

Two- to four-year-olds in the UK are for the second time being offered an egg-based nasal vaccine, and the UK will expand to older children. The intention is to prevent influenza (flu) in hopes of not just protecting children from getting flu, but also of stopping the disease spreading from them to their family, caregivers and the wider population. As we’ve indicated in our report on Biopharmaceutical and Vaccine production, http://www.kaloramainformation.com/Biopharmaceutical-Vaccine-Production...


Companion Diagnostics Alliances Mount - Clarient and GSK Deal Visited

Companion Diagnostics Alliances Mount - Clarient and GSK Deal Visited

In yet another sign that the ranks of recruitment are expanding in personalized medicine’s fight against cancer, GE Healthcare announced an agreement between its subsidiary Clarient Diagnostic Services and pharmaceutical giant GlaxoSmithKline (GSK). With GE Healthcare, the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. While operational details of the newly reached agreement have yet to be provided, certain parameters of the prog...